Opportunity Information: Apply for RFA DA 10 014

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Systems Biology, HIV/AIDS, and Substance Abuse (R01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
  • This funding opportunity was created on Jan 22, 2010 and posted on Jan 21, 2010.
  • Applicants must submit their applications by Apr 29, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $4,500,000.00 to eligible and selected applicants.
  • Each selected applicant is eligible to receive up to $750,000.00 in funding.
  • Eligible applicants include: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Public housing authorities/Indian housing authorities Private institutions of higher education State governments Native American tribal governments (Federally recognized) Others (see text field entitled Additional Information on Eligibility for clarification) Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education County governments.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
Apply for RFA DA 10 014

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The grant opportunity titled "Systems Biology, HIV/AIDS, and Substance Abuse (R01)" (Funding Opportunity Number RFA-DA-10-014) is a National Institutes of Health (NIH) discretionary research funding announcement focused on using systems biology to better understand the intersection of HIV/AIDS and substance use or abuse. The core idea is to encourage projects that do more than study single genes, single pathways, or isolated datasets. Instead, applicants are expected to use systems-level, integrative approaches that can connect and interrogate multiple complex databases at once, with the goal of revealing new conceptual frameworks, unexpected biological relationships, and novel research directions relevant to both HIV/AIDS and substance use.

From a scientific standpoint, the emphasis on "systems biology" signals that NIH is looking for research that combines large-scale or high-dimensional data and computational or quantitative modeling to understand complex biological and clinical phenomena. In practical terms, this can include integrating genomic, transcriptomic, proteomic, metabolomic, epigenomic, microbiome, clinical, behavioral, epidemiologic, and other data streams, then using network analysis, pathway modeling, multi-omics integration, machine learning, or mechanistic simulation approaches to generate testable insights. The opportunity is framed around discovery, meaning the program is explicitly interested in paradigms and hypotheses that might not emerge from more traditional, reductionist study designs, particularly in the complicated bidirectional relationship between substance use and HIV acquisition, progression, comorbidities, treatment response, and health outcomes.

The mechanism of support is the NIH R01, which is the standard investigator-initiated research project grant and typically supports well-developed, hypothesis-driven or discovery-driven projects with substantial scope. For this specific FOA, NIH set aside an estimated total of $4,500,000 to support awards. The announcement anticipates funding roughly 5 to 8 R01 grants, depending on scientific merit, program priorities, and the availability of appropriated funds. The award ceiling listed is $750,000, which indicates the maximum award amount expected under the announcement (often interpreted as a cap on direct costs in many NIH contexts, though applicants generally need to confirm budget rules in the full FOA text). As with most NIH opportunities, awards are contingent on both the quality of the applications received and the availability of funds.

This opportunity falls under CFDA 93.279, Drug Abuse and Addiction Research Programs, reinforcing that it sits within NIH's substance use research mission area while explicitly linking that mission to HIV/AIDS-related scientific questions. There is no cost sharing or matching requirement, which means applicants are not required to contribute non-federal funds as a condition of the award, a common feature of NIH research grants.

Eligibility is broad and includes a wide range of organization types. Eligible applicants include public and private institutions of higher education, nonprofits with and without 501(c)(3) status, for-profit organizations (including small businesses), state and local governments (including counties, cities, townships, and special district governments), independent school districts, public housing authorities/Indian housing authorities, and tribal governments and tribal organizations (federally recognized and other than federally recognized). The eligibility list also explicitly includes historically underrepresented and mission-specific institution types such as HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, and tribally controlled colleges and universities (TCCUs). Faith-based and community-based organizations are included, as are regional organizations, eligible federal agencies, and U.S. territories or possessions. Notably, the FOA also allows non-domestic (non-U.S.) entities and foreign organizations to apply, which opens the door to international research teams and cross-border collaborations where HIV and substance use burdens may be substantial and where relevant datasets and cohorts may exist.

Key administrative details show that the opportunity was posted in January 2010, with an original and current closing date of April 29, 2010, and an archive date of May 30, 2010. While the program is archived now, the details remain useful as a reference point for the type of research NIH has solicited at the HIV/substance use interface and for understanding how systems biology has been positioned within this space. The full announcement was hosted through the NIH Grants Guide, and technical access issues were directed to the NIH Office of Extramural Research (OER) webmaster contact.

Overall, this FOA was designed to push the field toward integrative, data-driven discovery that can connect biological mechanisms with clinical and behavioral realities, using systems biology to uncover relationships between substance use and HIV/AIDS that might otherwise remain hidden in siloed datasets. The expected outcome is not just incremental progress, but the generation of new models and hypotheses that can reshape how researchers investigate, prevent, and treat HIV in populations affected by substance use.

FAQs: Systems Biology, HIV/AIDS, and Substance Abuse (R01) (RFA-DA-10-014)

What is the title and funding opportunity number for this grant?

The opportunity is titled "Systems Biology, HIV/AIDS, and Substance Abuse (R01)" and the Funding Opportunity Number (FON) is RFA-DA-10-014.

Which agency is offering this grant opportunity?

This is a National Institutes of Health (NIH) discretionary research funding announcement.

What is the main goal of this funding opportunity?

The goal is to support systems biology research that improves understanding of the intersection between HIV/AIDS and substance use or abuse. The emphasis is on integrative, systems-level discovery that can reveal new biological relationships, conceptual frameworks, and research directions relevant to both areas.

What does NIH mean by "systems biology" in this context?

In this announcement, systems biology refers to approaches that move beyond studying single genes, single pathways, or isolated datasets. It emphasizes combining large-scale/high-dimensional data with computational or quantitative modeling to understand complex biological and clinical phenomena at a systems level.

What types of research approaches are encouraged?

The opportunity encourages integrative approaches that can connect and interrogate multiple complex databases and data streams at once. Examples mentioned include network analysis, pathway modeling, multi-omics integration, machine learning, and mechanistic simulation, with the intent of generating testable insights.

What kinds of data can be integrated in projects under this FOA?

The announcement describes integrating diverse data streams such as genomic, transcriptomic, proteomic, metabolomic, epigenomic, microbiome, clinical, behavioral, and epidemiologic data, among others.

Is this opportunity focused on hypothesis-driven research, discovery-driven research, or both?

It is framed around discovery and is explicitly interested in paradigms and hypotheses that may not emerge from traditional reductionist designs. At the same time, the R01 mechanism typically supports well-developed projects that can be hypothesis-driven or discovery-driven.

What relationship between HIV/AIDS and substance use is this FOA trying to better understand?

The FOA highlights the complex, bidirectional relationship between substance use and HIV acquisition, progression, comorbidities, treatment response, and health outcomes.

What funding mechanism is used for this opportunity?

The mechanism of support is the NIH R01 research project grant.

How much total funding was NIH expecting to commit to this announcement?

NIH set aside an estimated total of $4,500,000 to support awards under this announcement.

How many awards were anticipated?

The announcement anticipated funding roughly 5 to 8 R01 grants, depending on scientific merit, program priorities, and the availability of appropriated funds.

What is the award ceiling for this FOA?

The listed award ceiling is $750,000, described as the maximum award amount expected under the announcement.

Does this opportunity require cost sharing or matching funds?

No. The FOA states there is no cost sharing or matching requirement.

What is the CFDA number associated with this opportunity?

The opportunity is listed under CFDA 93.279, Drug Abuse and Addiction Research Programs.

Who is eligible to apply?

Eligibility is broad and includes many organization types, such as public and private institutions of higher education; nonprofits (with and without 501(c)(3) status); for-profit organizations (including small businesses); state and local governments; independent school districts; public housing authorities/Indian housing authorities; tribal governments and tribal organizations; faith-based and community-based organizations; regional organizations; eligible federal agencies; and U.S. territories or possessions.

Are historically underrepresented or mission-specific institution types explicitly included?

Yes. The eligibility list explicitly includes institution types such as HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, and tribally controlled colleges and universities (TCCUs).

Are non-U.S. (foreign) organizations allowed to apply?

Yes. The FOA allows non-domestic (non-U.S.) entities and foreign organizations to apply.

When was this opportunity posted, and what were the closing dates?

The opportunity was posted in January 2010. The original and current closing date is April 29, 2010.

Is this opportunity still active?

No. The announcement is archived. The archive date provided is May 30, 2010.

Where was the full announcement hosted?

The full announcement was hosted through the NIH Grants Guide.

Who was listed for technical access issues related to the announcement?

Technical access issues were directed to the NIH Office of Extramural Research (OER) webmaster contact.

What kind of outcomes was NIH expecting from funded projects?

The FOA emphasizes generating new models and hypotheses that can reshape how researchers investigate, prevent, and treat HIV in populations affected by substance use, rather than only producing incremental advances.

What is the key theme that distinguishes this FOA from more traditional studies?

The distinguishing theme is a strong push away from siloed, single-factor studies and toward systems-level, integrative, data-driven discovery that connects biological mechanisms with clinical and behavioral realities.

Browse more business programs for HIV and AIDS support

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Recovery Act Jupiter Inlet National Historic Lighthouse (LDDFR1400000)TAS 14 1112

Previous opportunity: The Access to Justice and Legal Empowerment Project in Ukraine

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DA 10 014

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DA 10 014) also looked into and applied for these:

Funding Opportunity
Pre Application for the 2010 NIDA Translational Avant Garde Award for Medication Development for Diseases of Addiction (X02) Apply for PAR 10 095

Funding Number: PAR 10 095
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
2010 NIDA Translational Avant Garde Award for Medication Development for Diseases of Addiction (DP1) Apply for RFA DA 10 013

Funding Number: RFA DA 10 013
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Medications Development for Substance Related Disorders (R01) Apply for RFA DA 10 018

Funding Number: RFA DA 10 018
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $1,000,000
Deep Sequencing and Analysis of Pharmacogenomic Regions Discovery and Analysis of Genetic Variants Contributing to Drug Abuse and Addiction (R01) Apply for RFA DA 10 019

Funding Number: RFA DA 10 019
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $250,000
Institutional Clinical and Translational Science Award (U54) Apply for RFA RM 10 001

Funding Number: RFA RM 10 001
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Technology Based Adherence Interventions for Substance Abusing Populations with HIV (R01) Apply for PAS 10 097

Funding Number: PAS 10 097
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $250,000
Technology Based Adherence Interventions for Substance Abusing Populations with HIV (R34) Apply for PAS 10 098

Funding Number: PAS 10 098
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $250,000
Chronic Co Morbid Conditions in HIV U.S. Adults on Highly Effective Anti Retroviral Therapy (R01) Apply for RFA NR 10 001

Funding Number: RFA NR 10 001
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
Chronic Co Morbid Conditions in HIV U.S. Adults on Highly Effective Anti Retroviral Therapy (R21) Apply for RFA NR 10 002

Funding Number: RFA NR 10 002
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows (Parent F31) Apply for PA 10 108

Funding Number: PA 10 108
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Comprehensive Partnerships to Reduce Cancer Health Disparities (Limited Competition U54) Apply for RFA CA 10 503

Funding Number: RFA CA 10 503
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Advancing Palliative Care Research for Children Facing Life Limiting Conditions (R21) Apply for RFA NR 10 007

Funding Number: RFA NR 10 007
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Advancing Palliative Care Research for Children Facing Life Limiting Conditions (R01) Apply for RFA NR 10 006

Funding Number: RFA NR 10 006
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Common Pathogenetic Mechanisms of Lung Cancer and COPD (R01) Apply for RFA HL 11 002

Funding Number: RFA HL 11 002
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Collaborative Clinical Trials in Drug Abuse (Collaborative R01) Apply for PAR 10 099

Funding Number: PAR 10 099
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Strategic Partnering to Evaluate Cancer Signatures SPECS II (U01) Apply for PAR 10 126

Funding Number: PAR 10 126
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Epigenetic Factors Associated with Symptoms and Complications of Chronic Disorders (Competitive Revision R01) Apply for RFA NR 10 005

Funding Number: RFA NR 10 005
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Epigenetic Factors Associated with Symptoms and Complications of Chronic Disorders (R01) Apply for RFA NR 10 004

Funding Number: RFA NR 10 004
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Drug Abuse Aspects of HIV/AIDS (R03) Apply for PA 10 131

Funding Number: PA 10 131
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Drug Abuse Aspects of HIV/AIDS (R01) Apply for PA 10 129

Funding Number: PA 10 129
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 10 014", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.